Skip to main content
Premium Trial:

Request an Annual Quote

Grifols Gets FDA Approval for Babesia Assay

NEW YORK (GenomeWeb) — Grifols said today that it has received US Food and Drug Administration approval for its Procleix assay for the detection of Babesia, a malaria-like parasite that can be transmitted through tick bites and donated blood.

The test is designed to detect ribosomal RNA from four clinically relevant Babesia species — B. microti, B. duncani, B. divergens, andB. venatorum —  in individual samples or up to 16 pooled lysed specimens from human donors, including donors of whole blood and blood components for transfusion. It is designed to run on the Barcelona, Spain-based company's fully automated Procleix Panther system, which performs nucleic acid testing for blood screening.

Grifols said that the approval follows the successful completion of a multicenter clinical trial performed under an investigational new drug study at the American Red Cross, Creative Testing Solutions, and Rhode Island Blood Center.

"The FDA approval of the Procleix Babesia assay is the latest significant milestone for Grifols and reinforces our strong commitment to helping health professionals decrease potential risks of infection from donated blood," Carsten Schroeder, president of Grifols' diagnostic commercial division, said in a statement.

Last year, the FDA approved Grifols' Procleix Zika virus assay, Procleix WNV West Nile virus assay, and Procleix Ultrio Elite combination HIV-1, hepatitis B, and hepatitis C assay.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.